LMND Q1 2026 Earnings EPS Beats Estimates by 186 Despite Stock Decline Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress FFWM Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Movement OHI Q1 2026 Earnings Strong EPS Surprise Amidst Flat Revenue Disclosure and Slight Stock Decline LGN Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction BORR Q1 2026 Earnings EPS Falls Short of Estimates by a Wide Margin OLED Q1 2026 Earnings Major EPS Miss Raises Concerns Amidst Growth Expectations LOW Q1 2026 Earnings EPS Beats Estimates Revenue Data Not Disclosed RWAYI Q1 2026 Earnings Net Investment Income Misses Estimates on Lower Yields DNOW Q1 2026 Earnings Significant EPS Miss Highlights Profitability Challenges MSDL Q1 2026 Earnings Small EPS Beat Meets Modest Market Pullback LARK Q1 2026 Earnings EPS of 083 Amidst Stock Decline